Related Experiment Video
Updated: Mar 7, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Laboratory Assessment of Direct Oral Anticoagulants
Jonathan Douxfils1, Robert C Gosselin2
1Department of Pharmacy, Namur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, University of Namur, Namur, Belgium.
Abstract:
Oral vitamin K anticoagulation (warfarin, Coumadin, coumarin) has long been used for long-term treatment and prophylaxis in a variety of clinical settings. Given the unpredictable pharmacokinetic and food impact of warfarin, episodic monitoring is required. Since the early 2000s, direct oral anticoagulants (DOACs) entered into clinical trials as a potential alternative strategy to oral vitamin K antagonists for long-term anticoagulation. As these drugs have predictable pharmacokinetics and pharmacodynamics, there was no requirement for episodic or routine monitoring. However, shortly after their introduction into clinical use, it became apparent that certain emergent or acute situations may require some capacity to measure these drugs, especially in a bleeding patient with DOAC exposure. The scramble for literature and data to support or suggest laboratory methods which can rapidly and accurately quantify or estimate DOAC concentration soon began. This review describes the literature to date, and recommendations for laboratories to provide tests that will assure either the presence/absence of DOAC or the capacity to quantify DOAC using rapid methods that could be implemented on most clinical laboratory instruments.
Insights
Direct oral anticoagulants (DOACs) offer predictable anticoagulation but may require laboratory measurement in emergencies. This review details methods for quantifying DOAC levels in clinical settings.
Area of Science:
- Clinical Chemistry
- Pharmacology
- Hematology
Background:
- Oral vitamin K antagonists (e.g., warfarin) require routine monitoring due to variable pharmacokinetics and food interactions.
- Direct oral anticoagulants (DOACs) were developed as alternatives with predictable profiles, initially obviating the need for monitoring.
- Emergent situations, particularly bleeding events, necessitate accurate measurement of DOAC concentrations.
Purpose of the Study:
- To review existing literature on laboratory methods for quantifying DOACs.
- To provide recommendations for clinical laboratories to implement rapid DOAC measurement techniques.
- To ensure the availability of tests for detecting DOAC presence/absence or quantifying levels.
Main Methods:
- Literature search for studies evaluating laboratory assays for DOAC quantification.
- Analysis of data regarding the accuracy, speed, and applicability of various methods.
- Assessment of recommendations for laboratory implementation.
Main Results:
- DOACs, despite predictable pharmacokinetics, require measurement in specific clinical scenarios.
- Various laboratory methods exist or are being developed to quantify DOAC concentrations.
- Rapid assays adaptable to standard clinical laboratory instruments are crucial.
Conclusions:
- Clinical laboratories need to be prepared to measure DOACs in acute situations.
- Implementing rapid quantification methods ensures appropriate patient management during emergencies.
- Standardized testing protocols are essential for reliable DOAC level assessment.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Assessment of the Mouth
Mouth Inspection
The inspection begins with visually examining the mouth for symmetry, color, and size.
Therapeutic Drug Monitoring: Drug Analysis Methods

